BRIEFLY

Stockwatch Daily - - HEALTH CARE -

- Abat­tis Bio­ceu­ti­cals Corp. has ob­tained DTC el­i­gi­bil­ity in the U.S. (ATT) $0.13

- Car­diome Pharma Corp. has re­ceived Health Canada ap­proval for its Ag­gra­s­tat high-dose bo­lus reg­i­men for treat­ing acute coro­nary syn­drome. (COM) $5.87

- Co­hbar Inc. has com­pleted a $5.16-mil­lion (U.S.) pri­vate place­ment con­sist­ing of 3.43 mil­lion units at $1.50 (U.S.) each. The com­pany will use the pro­ceeds for clin­i­cal stud­ies of its lead drug and gen­eral cor­po­rate pur­poses. (COB) $1.85

- CRH Med­i­cal Corp. es­ti­mates that the pro­posed fee sched­ule changes by the Cen­ter for Medi­care and Med­i­caid Ser­vices would lower its rev­enue by about 7.5 per cent. (CRH) $4.74

- He­lix BioPharma Corp.’s Al­bert Ber­aldo has quit as a di­rec­tor of the com­pany. (HBP) $0.90

- Kane Biotech Inc. has closed a $4-mil­lion pri­vate place­ment of 33.33 mil­lion units at 12 cents each. It will use the pro­ceeds for busi­ness de­vel­op­ment, patent fil­ings, clin­i­cal tri­als and gen­eral work­ing cap­i­tal. (KNE) $0.11

- Lat­tice Bi­o­log­ics Ltd. has closed the is­suance of 491,363 shares and 491,363 war­rants to set­tle a debt of $93,359. Also, it has re­ceived TSX-V ap­proval to is­sue 98,885 shares for ser­vices it re­ceived in May, 2017. (LBL) $0.10

- Medi­cenna Ther­a­peu­tics Corp. has ap­pointed Dr. Jay Stoudemire as CSO. Dr. Stoudemire has held se­nior po­si­tions at Ge­nen­tech, As­centa Ther­a­peu­tics, Chugai-Roche Phar­ma­ceu­ti­cals, Cy­tel, Ge­net­ics In­sti­tute and Xoma. (MDNA) $1.80

- Preve­ceu­ti­cal Med­i­cal Inc. has en­tered a four-year re­search pro­gram with UniQuest Pty. Ltd. to de­velop a dual-gene ther­apy for treat­ing di­a­betes and obe­sity. Preve­ceu­ti­cal will own all IP de­vel­oped un­der this pro­gram. (PREV) $0.68

- Ze­cotek Pho­ton­ics Inc.’s Ze­cotek China has ap­pointed Thomas Lau as busi­ness de­vel­op­ment di­rec­tor. (ZMS) $0.29

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.